整合素连接激酶在胶质瘤发生发展中的作用

doi:10.3969/j.issn.1674-490X.2013.05.021

摘要/Abstract

摘要： 整合素连接激酶（ILK）广泛表达于多种组织细胞中，与多项细胞生理过程密切相关。近来研究发现，它还参与了肿瘤细胞的增殖、凋亡、侵袭转移、血管生成等过程，在极大程度上促进了肿瘤的发展。与此同时，科学家们在对胶质瘤的研究中也发现了类似的结果。综述了近年来关于整合素连接激酶在胶质瘤中的研究成果。

关键词: 整合素连接激酶, 胶质瘤, 转移侵袭, 血管生成

Abstract: Integrin-Linked kinase (ILK) is widely expressed in multiple tissues cells, closely related to various cellular physiological processes. Recent studies have found that it is involved in tumor cell proliferation, apoptosis, invasion and metastasis, angiogenesis and so on, for the most part to promote the development of tumor. At the same time, the scientists also found in the study that glioma had similar results. This article will discuss about the integrin-linked kinase on glioma in recent years’ research.

Key words: integrin-linked kinase, transfer, glioma, angiogenesis

中图分类号:

R651.1

崔冬强,王洪,李春晖. 整合素连接激酶在胶质瘤发生发展中的作用[J]. 医学研究与教育, 2013, 30(5): 79-82.

CUI Dongqiang,WANG Hong,LI Chunhui. Effects of Integrin-linked kinase in the development of glioma[J]. Medical Reserch and Education, 2013, 30(5): 79-82.

参考文献

[1] 李晋辉, 母得志, LI Jinhui, MU Dezhi. 整合素及其信号传导通路 [J]. 医学分子生物学杂志 2007.doi:10.3870/j.issn.1672-8009.2007.03.022
[2] 孙晓杰, 黄常志, Sun XJ, Huang CZ. PI3K-Akt信号通路与肿瘤 [J]. 世界华人消化杂志 2006.doi:10.3969/j.issn.1009-3079.2006.03.011
[3] 戚晓平, 方丽, 林考兴, 许龙根, 阎利, 李峰, 戴晓纹. 整合素连接激酶在前列腺癌组织中的表达及意义 [J]. 中华男科学杂志 2005.doi:10.3969/j.issn.1009-3591.2005.01.008
[4] 王小强, 张建生, 霍龙伟, 杨鹏宇, 许武, WANG Xiaoqiang, ZHANG Jiansheng, HUO Longwei, YANG Pengyu, XU Wu. ILK与PKB在人脑胶质瘤组织中的表达及临床意义 [J]. 中华神经外科疾病研究杂志 2010.doi:10.3969/j.issn.1671-2897.2010.01.005
[5] 李清, 徐涛, 何培英, 郝一昌, 王晓峰, LI Qing, XU Tao, HE Pei-ying, HAO Yi-chang, WANG Xiao-feng. 整合素连接激酶对裸鼠前列腺癌的影响 [J]. 北京大学学报（医学版） 2010.doi:10.3969/j.issn.1671-167X.2010.04.004
[6] HANNIGAN G, LEUNG C, FITZ-GIBBON L. Regulation of cell adhesion andanchorage-dependent growth by a new beta 1-integrin-linked protein kinase [J]. Nature 1996, 379(6560).
[7] McDonald PC, Fielding AB, Dedhar S. Integrin-linked kinase--essential roles in physiology and cancer biology. [J]. Journal of Cell Science 2008, 19(19).
[8] EDWARDS L, VERREAULT M, THIESSEN B. Combined inhibition of the phosphatidylinositol 3-kinase/Akt and Ras/mitogen-activated protein kinase pathways results in synergistic effects in glioblastoma cells [J]. Molecular Cancer Therapeutics 2006, 5(03).
[9] YOGANAYHAN N, YEE A, ZHANG Z. Integrin-linked kinase, a prossing cancer therapeutic target:biochemical and biological properties [J]. Pharmacology and Therapeutics 2002, 93(02).
[10] CHUANYUE W U, SHOUKAT D. Integrin-linked kinase(ILK)and its interactors:a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexe [J]. Journal of Cell Biology 2001, 155(04).
[11] Troussard AA, Mawji NM, Ong C, Mui A, St Arnaud R, Dedhar S. Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. [J]. The Journal of biological chemistry 2003, 25(25).
[12] Lynch DK, Ellis CA, Edwards PA, Hiles ID. [J]. Oncogene 1999.
[13] DIMPY K, SHEN Ruijun, SHERRY B. Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma [J]. Molecular Cancer Therapeutics 2005, 4(11).
[14] SOICHI O, MASANORI N, HIDEO T. Integrin-Linked kinase(ILK)regulation of the cell viability in PTEN mutant Glioblastoma and in vitro inhibition by the specific COX-2 inhibitor NS-39 [J]. Cancer Letters 2004, 208.
[15] Wong RP, Ng P, Dedhar S, Li G. [J]. Molecular cancer therapeutics 2007.
[16] 吕磊, 曾甫清, 朱朝辉, 董锐, 黄露麒. siRNA特异性沉默整合素连接激酶对前列腺癌PC3细胞凋亡的影响 [J]. 中国肿瘤 2009.
[17] LINCOLN A, THIESSEN B, WIESLAWA H. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/AKt activation, inhuces apoptosis, and delays tumor growth [J]. Oncogene 2005, 24.
[18] Kaneko Y, Kitazato K, Basaki Y. [J]. Journal of Cell Science 2004.
[19] 孙晓杰, 林梁, 赵玫, 黄常志, SUN Xiao-Jie, LIN Liang, ZHAO Mei, HUANG Chang-zhi. ILK与HSP90相互作用对乳腺癌细胞迁移影响及其机制的探讨 [J]. 中华肿瘤防治杂志 2012.
[20] ZHU Xiangyu, LIU Ning, LIU Wei. Silencing of the integrin-linked kinase gene suppresses the proliferation, migration and invasion of pancreatic cancer cells(Panc-1) [J]. Genetics and Molecular Biology 2012, 35(02).
[21] DAVID G, JEAN-F G, YANNICK D. Integrin-Linked Kinase regulation migration and proliferation of human intestinal cells under a fibronectin-dependent mechanism [J]. Journal of Cellular Physiology 2012, 222.
[22] Edwards LA, Woo J, Huxham LA, Verreault M, Dragowska WH, Chiu G, Rajput A, Kyle AH, Kalra J, Yapp D, Yan H, Minchinton AI, Huntsman D, Daynard T, Waterhouse DN, Thiessen B, Dedhar S, Bally MB. Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK). [J]. Molecular cancer therapeutics 2008, 1(1).
[23] DUXBURY M, ITO H, BENOIT E. RNA interference demonstrate a novel role for integrin-linked kinase as a determinant of pancreatic adenocarcinoma cell gemcitabine chemoresistance [J]. Clinical Cancer Research 2005, 11(09).
[24] CHIARA V, GIULIO B, VALENTINA C. Anti-Angiogenic therapy Induces Integrin-linked kinase 1 up-regulation in a Mouse model of Glioblastoma [J]. PLoS ONE 2010, 5(10).
[25] Durbin AD, Wong DK, Malkin D. The oncogenic and growth-suppressive functions of the integrin-linked kinase are distinguished by JNK1 expression in human cancer cells. [J]. Cell cycle 2010, 10(10).
[26] Abboud ER, Coffelt SB, Figueroa YG, Zwezdaryk KJ, Nelson AB, Sullivan DE, Morris CB, Tang Y, Beckman BS, Scandurro AB. Integrin-linked kinase: a hypoxia-induced anti-apoptotic factor exploited by cancer cells. [J]. International journal of oncology 2007, 1(1).